simcere logo.png

Simcere Innovation

Simcere Pharmaceutical Group is China's leading R&D-driven pharmaceutical company.


Simcere was the first Chinese biological and chemical-pharmaceutical company to be listed on the New York Stock Exchange.


The national key laboratory for translational medicine and innovative drugs has been approved by the Ministry of Science and Technology. They are striving to make new medicines available to our patients sooner.